Karmanos Cancer Institute

McLaren Greater Lansing

Lansing, MI

Sorting 3 by

Accepting patients

Horizon Adaptive Platform

MMRC Horizon One: RRMM (MMRC-099)
Learn more
  • Bispecific Antibody
  • BCMA
  • CD3
  • Randomization
  • Phase 2

Accepting patients

CERVINO

A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Learn more
  • Bispecific Antibody
  • BCMA
  • Randomization
  • Phase 3

Accepting patients

IBEX

IBEX: Phase 2 Trial of Iberdomide + SQ Daratumumab as Post-Autologous Stem Cell Transplant Maintenance Therapy in Multiple Myeloma
Learn more
  • CELMoD
  • Maintenance
  • Phase 2
1 hidden based on your filters.Show All